Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
B-HT 933 is an agonist of α2-adrenergic receptors (α2-ARs) with an EC50 value of 0.65 μM for contraction of canine sapheneous veins.1 It induces concentration-dependent inhibition of the twitch response in rat vas deferens and guinea pig ileum.2 B-HT 933 induces sedation and reduces motor activity in mice, an effect that is reversed by the α2-AR antagonist yohimbine (Item No. 19869).3 B-HT 933 decreases blood pressure and cardiac output in cats injected with 30 μg/kg intracisternally.4 It also exhibits antinociceptive effects in mice with ED50 values of 12.5, 20.5, and 6.1 mg/kg for the tail-immersion, tail-pinch, and acetic acid writhing tests, respectively.5
WARNING This product is not for human or veterinary use.
1. Relationship between alpha 2-
2. Mechanism of action of B-
3. Selective stimulation of dopamine and noradrenaline autoreceptors by B-
4. Tramiprostate, a drug of potential interest for the treatment of Alzheimer’s disease, promotes an abnormal aggregation of tau. Mol. Neurodegener. 2, 17-29 (2007).
5. Antinociceptive effects of azepexole (BHT 933) in mice. Pain 36(1), 117-123 (1989).